AXON ENTERPRISE, INC.
Historical Data
View all| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 3, 2026 | $29.80 | $29.89 | $29.72 | $29.83 | 3.77M |
| Jul 2, 2026 | $29.52 | $30.01 | $29.26 | $29.80 | 3.03M |
| Jul 1, 2026 | $29.48 | $29.67 | $29.31 | $29.52 | 3.37M |
| Jun 30, 2026 | $29.64 | $30.07 | $29.05 | $29.48 | 4.15M |
| Jun 29, 2026 | $29.68 | $29.73 | $29.50 | $29.64 | 3.79M |
| Jun 28, 2026 | $29.22 | $29.92 | $29.05 | $29.68 | 4.65M |
| Jun 27, 2026 | $29.19 | $29.61 | $28.91 | $29.22 | 3.36M |
| Jun 26, 2026 | $29.15 | $29.31 | $29.05 | $29.19 | 3.94M |
Company Overview
AXON ENTERPRISE, INC. operates in the technology space within the Technology sector. The company generates the majority of its revenue from operating momentum, and has built a durable competitive position through scale, brand, and continued reinvestment. It serves customers globally and is headquartered in the United States. Reported figures on this page are generated for demonstration and are not investment advice.
Leadership
Board 13 · Independent 12 of 13| Date | Firm | Target | Rating |
|---|---|---|---|
| Jun 29 | Wedbush | $45.47 | Buy |
| Jun 29 | Wedbush | $38.22 | Neutral |
| Jun 9 | Morgan Stanley | $49.86 | Reduce |
| May 30 | Morgan Stanley | $30.00 | Overweight |
| May 29 | Melius Research | — | Overweight |
| May 19 | Wedbush | $35.25 | Strong Buy |
Politician Trades
View allWhat's Happening Right Now
- Sep 18, 2026 · Financing ↗ — Axon priced a $1 billion convertible notes offering, with the company saying its growth outlook remains strong despite the stock's reaction.
- Sep 17, 2026 · Financing ↗ — Shares fell 9.8% at the open following the convertible note offering announcement.
- Sep 16, 2026 · Financing ↗ — Axon shares reportedly rose after the $1 billion convertible notes offering was priced, per an earlier report.
- Sep 17, 2026 · Trading ↗ — A fund was noted capitalizing on Axon shares amid a broader AI-related selloff.
- Sep 17, 2026 · Analyst ↗ — Brokerages currently give Axon Enterprise an average recommendation of 'Moderate Buy.'
Snapshot
No annual report (Form 10-K) is currently on file for Axon Enterprise, so specific revenue, profit, and balance-sheet figures are not available at this time. Recent activity centers on a $1 billion convertible notes offering priced in mid-September 2026, which triggered notable stock price swings, including a reported 9.8% intraday drop tied to the news. Institutional investors, including Nykredit A/S and Bank of America Corp DE, have disclosed new share purchases in the stock during this period. Brokerage sentiment is currently rated a "Moderate Buy" on average, though the stock has shown underperformance relative to peers and the broader market on multiple recent trading days.
Bottom Line
Without audited financial figures on file, this summary cannot ground an assessment of Axon's fundamentals, leaving the investment case reliant on market and financing developments alone. The $1 billion convertible notes offering appears to be the dominant near-term catalyst, injecting both capital and stock volatility, while institutional buying and a "Moderate Buy" analyst consensus suggest underlying confidence. The tradeoff for investors is balancing recent share-price weakness and dilution risk from the convertible notes against continued institutional accumulation and a still-positive brokerage outlook.